Back to Search
JORDAN BLESSING, MD
MD
Pediatrics Physician
NPI: 1073907291Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Phase II trial of ixabepilone as second-line treatment in advanced endometrial cancer: gynecologic oncology group trial 129-P.
PMID 19451430·J Clin Oncol·2009
3-trial
Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group.
PMID 19332726·J Clin Oncol·2009
3-trial
Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study.
PMID 18191993·Gynecol Oncol·2008
3-trial
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.
PMID 18534250·Gynecol Oncol·2008
3-trial
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.
PMID 18394689·Gynecol Oncol·2008
3-trial
Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
PMID 18455781·Gynecol Oncol·2008
3-trial
A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: a study by the Gynecologic Oncology Group.
PMID 18675446·Gynecol Oncol·2008
3-trial
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
PMID 17049588·Gynecol Oncol·2007
3-trial
Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
PMID 17762444·Am J Clin Oncol·2007
3-trial
Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
PMID 16271750·Gynecol Oncol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 111 COLCHESTER AVE, UVM MEDICAL CENTER, DEPT OF INTERNAL MEDICINE, 222WP2
BURLINGTON, VT 05401 - Phone
- (802) 847-2700
Quick Facts
- NPI
- 1073907291
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile